Sharif et al. (2016) [59] explained that NMNAT2 is a key enzyme in a salvage pathway via p73 for the cancer cell viability, which may verify the important role of NMNAT2 for the RTK inhibitor treatment on breast cancer cells. This evidence concerns the gene NMNAT2 and breast carcinoma.